GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » EV-to-Revenue

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) EV-to-Revenue : 4.64 (As of May. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zhejiang Jolly Pharmaceutical Co's enterprise value is ¥9,836 Mil. Zhejiang Jolly Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,120 Mil. Therefore, Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue for today is 4.64.

The historical rank and industry rank for Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SZSE:300181' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.66   Med: 5.19   Max: 17.4
Current: 4.64

During the past 13 years, the highest EV-to-Revenue of Zhejiang Jolly Pharmaceutical Co was 17.40. The lowest was 2.66. And the median was 5.19.

SZSE:300181's EV-to-Revenue is ranked better than
64.29% of 1039 companies
in the Biotechnology industry
Industry Median: 8.18 vs SZSE:300181: 4.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Zhejiang Jolly Pharmaceutical Co's stock price is ¥15.18. Zhejiang Jolly Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.04. Therefore, Zhejiang Jolly Pharmaceutical Co's PS Ratio for today is 4.99.


Zhejiang Jolly Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co EV-to-Revenue Chart

Zhejiang Jolly Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.72 3.46 4.90 3.67 3.43

Zhejiang Jolly Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.19 4.11 3.58 3.43 3.91

Competitive Comparison of Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue

For the Biotechnology subindustry, Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue falls into.



Zhejiang Jolly Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9836.154/2119.642
=4.64

Zhejiang Jolly Pharmaceutical Co's current Enterprise Value is ¥9,836 Mil.
Zhejiang Jolly Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jolly Pharmaceutical Co  (SZSE:300181) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Zhejiang Jolly Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=15.18/3.043
=4.99

Zhejiang Jolly Pharmaceutical Co's share price for today is ¥15.18.
Zhejiang Jolly Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jolly Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Business Description

Traded in Other Exchanges
N/A
Address
No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
Executives
Shen Ai Ying Executives
Chen Guo Fen Executives
Yu You Qiang Director
Chen Jian Executives
Zheng Xue Gen Director
Guo Yin Li Supervisors
Wang Tao Executives
Yang Jun De Director
Chen Rui Xiang Supervisors
Dong Hong Yu Directors, executives
Zheng Chao Yi Directors, executives
Zhu Xiao Ping Executives
Wu Ying Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Headlines

No Headlines